On November 28, at the "2025 CSSC Hydrogen Energy Day" event held in Handan, Hebei, REFIRE officially signed a cooperation agreement for the joint development of marine fuel cell systems with Wuhan ...
BMW Group Plant Steyr is getting ready for series production of fuel cell systems. The third generation of the BMW Group’s hydrogen drive system will be manufactured in Steyr from 2028, and the ...
Mesoblast (NASDAQ:MESO) added ~13% in the morning hours on Tuesday after the Australian biotech said that the FDA agreed with the company regarding key components of a marketing application (BLA) ...
An open-label, phase I trial of the SIRPα monoclonal antibody, BI 770371, alone and in combination with the PD-1 inhibitor ezabenlimab in patients with advanced solid tumors. This is an ASCO Meeting ...
Hamburg-based Minebea Intec GmbH says its load cell technology is helping owners of truck scales welcome a high volume of traffic while offering a high level of precision weighing. The global ...
TOKYO & MUNICH--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab ...
– Application is based on data from the Phase III STARGLO study where Columvi plus chemotherapy showed a statistically significant and clinically meaningful improvement in overall survival – – This ...
HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (FBLG) , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and ...
The submission is supported by data from the pivotal WU-KONG1 Part B study, which featured in an oral session at the 2024 ASCO Annual Meeting Sunvozertinib is the world's first and only oral drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback